Infrared light scanning of the breast.

Area of Science:

• Medical Imaging
• Oncology
• Diagnostic Technology

Background:

• Breast cancer diagnosis relies on mammography, clinical breast exams, and increasingly, advanced imaging techniques.
• Transillumination and Infrared Light Scanning (I.L.S.) offer alternative methods for breast tissue evaluation.
• Optimizing diagnostic accuracy is crucial for early breast cancer detection and patient outcomes.

Purpose of the Study:

• To evaluate the diagnostic performance of transillumination alone and in combination with I.L.S. for breast pathology.
• To compare the sensitivity and specificity of these methods against mammography and clinical breast examination.
• To determine the added value of I.L.S. in identifying breast carcinomas.

Main Methods:

• A prospective study involving 700 patients in a high-referral breast clinic over 15 months.
• Phase I: Transillumination without I.L.S. (22 biopsies, 8 carcinomas).
• Phase II: Transillumination combined with I.L.S. (79 biopsies, 26 carcinomas).

Main Results:

• Transillumination alone showed 87% sensitivity and 64% specificity.
• Transillumination with I.L.S. achieved 96% sensitivity and 74% specificity, outperforming mammography and clinical exams.
• I.L.S. identified carcinomas missed by palpation or mammography in Phase II.

Conclusions:

• Infrared Light Scanning (I.L.S.) combined with transillumination significantly enhances breast cancer detection rates.
• This combined approach offers superior sensitivity and specificity compared to conventional methods.
• I.L.S. is recommended as an adjunct to routine breast examination or mammography to improve diagnostic yield.